Sorrell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 2154.98%
(FY 2020)
- Profit 68.31%
(FY 2020)
- Ebitda 4.71%
(FY 2020)
- Net Worth -22.59%
(FY 2020)
- Total Assets 67.74%
(FY 2020)
About Sorrell Pharmaceuticals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anumalasetty Tarakanadh and Venkata Guttula serve as directors at the Company.
- CIN/LLPIN
U24304TG2017PTC116536
- Company No.
116536
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sorrell Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anumalasetty Tarakanadh  | Director | 14-Dec-2023 | Current |
| Venkata Guttula | Additional Director | 13-Mar-2023 | Current |
Financial Performance of Sorrell Pharmaceuticals.
Sorrell Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 2154.98% increase. The company also saw a substantial improvement in profitability, with a 68.31% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sorrell Pharmaceuticals?
Unlock access to Sorrell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sultan Health Care And Cosmetics Private LimitedActive 2 years 3 monthsAnumalasetty Tarakanadh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sorrell Pharmaceuticals?
Unlock and access historical data on people associated with Sorrell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sorrell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorrell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
